ALPHA Sitagliptin Add on to Metformin (0431-103)

Clinical trial NCT00833027 · COMPLETED

Trial details

NCT number: NCT00833027
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus

Start date: 2008-03-01
Primary completion: 2009-10-30
Enrollment: 608

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.